Perrigo | PRGO - Interest Expense On Debt


Perrigo reported $7.98B in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
AbbVie USD 645M 69M Mar/2026
Abbott USD 299M 231M Jun/2026
Bayer EUR 675M 87M Dec/2025
Bristol-Myers Squibb USD 407M 4M Jun/2026
Coherus Biosciences USD 2.25M 76K Dec/2025
Corcept Therapeutics USD 888.7M 73.82M Jun/2026
Dr.Reddys Laboratories INR 1.26B 198M Jun/2026
Eli Lilly USD 114.7M 134.3M Sep/2025
J&J USD 43M 25M Mar/2026
Merck USD 525M 46M Jun/2026
Nestle CHF 862M 35M Jun/2026
Pacira USD 3.62M 77K Jun/2026
Perrigo USD 7.98B 7.94B Mar/2026
Pfizer USD 667M 4M Jun/2026
Phibro Animal Health USD 11.91M 191K Dec/2025
Prestige Brands USD 10.67M 636K Dec/2025
Reckitt Benckiser GBP 208M 198.3M Dec/2024
Sanofi EUR 287M 109M Jun/2026
Supernus Pharmaceuticals USD 910K 278K Jun/2023
Teva Pharmaceutical Industries USD 195M 21M Jun/2026
Xeris Pharmaceuticals USD 6.88M 269K Mar/2026
Zoetis USD 62M 5M Mar/2026